Anzeige
Mehr »
Login
Sonntag, 26.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 02.10.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
02.10.24Scorpius Holdings, Inc.: Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats48DURHAM, N.C., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) ("Scorpius" or "the Company"), an integrated contract development and manufacturing organization ("CDMO")...
► Artikel lesen
02.10.24SolaX Power Announces 1.498 Billion USD Investment in Energy Storage and Smart Energy Facility193HANGZHOU, China, Oct. 2, 2024 /PRNewswire/ -- SolaX Power, a global leader in energy storage solutions, has unveiled a 149.8 million USD investment to establish a cutting-edge research and manufacturing...
► Artikel lesen
02.10.24Dr. Reddy's signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries134HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as "Dr. Reddy's"), today...
► Artikel lesen
02.10.24MDU Resources Group, Inc.: MDU Resources Board of Directors Approves Everus Spinoff, Declares Distribution of Shares of Everus98BISMARCK, N.D., Oct. 2, 2024 /PRNewswire/ -- MDU Resources Group, Inc. (NYSE: MDU) announced today that its board of directors has approved the previously announced spinoff of the company's wholly...
► Artikel lesen
02.10.24Amnode AB has received conditional approval for listing on NGM46Amnode AB ("Amnode") has received conditional approval for listing on Nordic SME at the Nordic Growth Market. The first trading day is expected to be October 15, 2024. Amnode is an industrial group....
► Artikel lesen
02.10.24Saltire Capital Ltd.: Saltire Capital, Ltd. Commences Trading on the Toronto Stock Exchange (TSX)77TORONTO, Oct. 2, 2024 /CNW/ - Saltire Capital, Ltd. ("Saltire" or the "Company") is pleased to announce that its common shares and warrants have commenced trading on the Toronto Stock Exchange...
► Artikel lesen
02.10.24MicroCloud Hologram Inc. Announces Results of its 2024 Annual General Meeting of the Shareholders649SHENZHEN, China, Oct. 2, 2024 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), (the "Company"), today announced that its 2024 Annual General Meeting of the Shareholders (the "AGM") was...
► Artikel lesen
02.10.24CONTACT ENERGY LIMITED: NZX Capital Change Notice - Capital Bond-
02.10.24FREIGHTWAYS GROUP LIMITED: Retirement of Director-
02.10.24StandardAero Announces Pricing of its Upsized Initial Public Offering340SCOTTSDALE, Ariz.--(BUSINESS WIRE)--StandardAero, Inc. ("StandardAero") announced today the pricing of its initial public offering of 60,000,000 shares of its common stock, at a public offering...
► Artikel lesen
02.10.24Alstom schließt Werk in Görlitz bis März 2026507BERLIN (dpa-AFX) - Der französische Zugbauer Alstom will das Werk in Görlitz mit derzeit rund 700 Mitarbeitern bis Ende März 2026 schließen. Grund sei die strategische Verlagerung von Rohbauarbeiten...
► Artikel lesen
02.10.24Ero Copper Corp.: Ero Copper Announces Initial NI 43-101 Mineral Resource Estimate for the Furnas Copper-Gold Project166VANCOUVER, British Columbia, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) ("Ero" or the "Company") is pleased to announce an initial National Instrument 43-101 ("NI 43-101")...
► Artikel lesen
02.10.24NOVAGOLD RESOURCES INC.: NOVAGOLD Reports Third Quarter 2024 Financial Results223Focused on Progressing the Donlin Gold Project to a Fully Updated Feasibility Study Wide-Ranging Community Involvement and Government Engagement to Sustain Donlin Gold's Social License Strong...
► Artikel lesen
02.10.24Innventure, Inc.: Innventure LLC and Learn CW Investment Corporation Announce Closing of Business Combination150ORLANDO, Fla., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Innventure, Inc. (Nasdaq: INV) and Learn CW Investment Corporation (NASDAQ: LCW) ("Learn CW"), a special purpose acquisition company, today announced...
► Artikel lesen
02.10.24Spero Therapeutics, Inc.: Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy132CAMBRIDGE, Mass., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments...
► Artikel lesen
02.10.24Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)101SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ("Olema" or "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development...
► Artikel lesen
02.10.24Silynxcom Ltd.: Silynxcom Announces Results for First Half of 2024; Significant Revenue Growth and Improvement in Gross Margin116NETANYA, Israel, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE American: SYNX) ("Silynxcom" or the "Company"), a manufacturer and developer of ruggedized tactical communication headset devices...
► Artikel lesen
02.10.24Xilio Therapeutics, Inc.: Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)112WALTHAM, Mass., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies...
► Artikel lesen
02.10.24Mural Oncology, Inc.: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)90WALTHAM, Mass. and DUBLIN, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies...
► Artikel lesen
02.10.24Solid Biosciences Inc.: Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)127CHARLESTOWN, Mass., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company"), a life sciences company developing precision genetic medicines for neuromuscular and cardiac...
► Artikel lesen
Seite:  Weiter >>